Tools & Calculators
Sector: Pharmaceuticals & Biotechnology
|Mid Cap
Supriya Lifescience Ltd.
₹670
Invest in SUPRIYA with up to 2.22x margin.
Trade with MTF₹667.50
₹683.70
₹556.15
₹842.00
Markets Today
Historical Performance
Indicator | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|
| Total Revenue | 206.44 | 199.83 | 145.07 | 184.11 | 185.65 |
| Operating Expense | 134.36 | 127.19 | 93.37 | 116.52 | 119.70 |
| Operating Profit | 72.08 | 72.65 | 51.70 | 67.58 | 65.95 |
| Depreciation | 6.82 | 6.64 | 6.45 | 6.08 | 4.96 |
| Interest | 0.49 | 0.42 | 0.51 | 0.42 | 0.51 |
| Tax | 17.24 | 17.89 | 12.62 | 13.68 | 15.80 |
| Net Profit | 49.68 | 50.43 | 34.79 | 50.38 | 46.78 |
₹670.00
↗ Bullish Moving Average
0
↘ Bearish Moving Average
16
| Held By | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|
| Promoter | 68.3 | 68.3 | 68.3 | 68.3 | 68.3 | 68.3 |
| FII | 6 | 6.5 | 7.2 | 6.8 | 5.5 | 5.2 |
| DII | 5.5 | 4.9 | 4.2 | 4.8 | 5.2 | 5 |
| Public | 20.2 | 20.2 | 20.2 | 20.1 | 21 | 21.5 |
| Period | Combined Delivery Volume | NSE+BSE Traded Volume Avg | Daily Avg Delivery Volume % |
|---|---|---|---|
| Day | 25.56 K | 53.57 K | 47.72% |
| Week | 1.11 L | 1.61 L | 68.88% |
| 1 Month | 94.99 K | 1.75 L | 54.35% |
| 6 Month | 1.11 L | 2.31 L | 48.07% |
Companies with no Debt
Benjamin Graham Value Screen
Consistent high performing stocks over Five Years
Mid-range Performer (DVM)
Rising Net Cash Flow and Cash from Operating activity
Annual Profit Growth higher than Sector Profit Growth
Effectively using its capital to generate profit - RoCE improving in last 2 years
Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year
Efficient in managing Assets to generate Profits - ROA improving since last 2 year
Increasing Revenue every quarter for the past 2 quarters
Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years
Annual Net Profits improving for last 2 years
Book Value per share Improving for last 2 years
Companies with Zero Promoter Pledge
Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| 04 Sep, 2025 | 1 | FINAL | 05 Sep, 2025 | Equity Share |
| 20 Sep, 2024 | 0.8 | FINAL | Equity Share | |
| 15 Sep, 2023 | 0.6 | FINAL | Equity Share | |
| 01 Sep, 2022 | 0.6 | FINAL | Equity Share |
Financials | ||||||
|---|---|---|---|---|---|---|
| Price (₹) | ₹1,577 | ₹628.95 | ₹780 | ₹968 | ₹1,320 | ₹4,075 |
| % Change | 3.47% | -5.40% | -0.01% | 2.83% | 3.96% | 0.75% |
| Revenue TTM (₹ Cr) | - | - | ₹1,598.19 | ₹2,169.86 | ₹1,419.33 | ₹798.10 |
| Net Profit TTM (₹ Cr) | - | - | ₹206.20 | ₹332.94 | ₹20.10 | ₹217.90 |
| PE TTM | - | - | 62.20 | 61.50 | 754.90 | 43.10 |
| 1 Year Return | 48.29 | 6.51 | 60.63 | 37.17 | 3.9 | -12.48 |
| ROCE | 30.24 | 34.78 | 34.76 | 12.51 | 3.26 | - |
Akums Drugs & Pharmaceuticals Ltd.
₹ 474.00
-0.91%
Blue Jet Healthcare Ltd
₹ 391.40
+9.99%
Concord Biotech Ltd.
₹ 1103.00
+0.46%
Aarti Pharmalabs Ltd.
₹ 687.60
-1.60%
Acutaas Chemicals Ltd.
₹ 2138.50
+1.52%
Alivus Life Sciences Ltd.
₹ 901.15
-1.08%
Cohance Lifesciences Ltd.
₹ 315.10
+3.18%
Eris Lifesciences Ltd.
₹ 1358.00
+1.16%
Syngene International Ltd.
₹ 448.60
+1.33%
Alembic Pharmaceuticals Ltd.
₹ 774.90
+1.55%
Strides Pharma Science Ltd.
₹ 872.90
+0.37%
Granules India Ltd.
₹ 598.00
-0.18%
FDC Ltd.
₹ 383.00
+3.82%
Shilpa Medicare Ltd.
₹ 329.00
+1.29%
Jubilant Pharmova Ltd.
₹ 900.00
+3.15%
Natco Pharma Ltd.
₹ 886.00
-0.64%
Caplin Point Laboratories Ltd.
₹ 1739.00
+2.77%
Neuland Laboratories Ltd.
₹ 13507.00
+6.88%
Marksans Pharma Ltd.
₹ 179.32
+0.53%
Sanofi India Ltd.
₹ 4080.00
+1.34%
Procter & Gamble Health Ltd.
₹ 5080.00
+1.21%
Jeena Sikho Lifecare Ltd.
₹ 674.90
-2.16%
By signing up I certify terms, conditions & privacy policy